Orchestra BioMed COO Darren Sherman reports acquisition of 2,000 common shares valued at $10,660
OBIO•Change in beneficial ownership disclosed
Orchestra BioMed disclosed a change in beneficial ownership by Darren Sherman, President and Chief Operating Officer.
- Sherman’s direct holdings fell by 4,925 common shares at $5.26, leaving 1,149,402 shares.
- A separate 2,000-share common stock purchase at $5.33 was reported as indirectly held by his son.
